Robert Paul Leitao on Premarket: Apple is green - 'In other market news Oracle dropped $8.69 or 5.38% to $152.94 and jumped AH following the release of earnings. Overnight the shares are up $8.10 or 5.30% at $161.04. Results (obviously) came in well above expectations along with strong guidance to move the shares higher. Adobe, which also reported after the bell, closed down $.6.03 or 2.37% at $248.83. Although results also beat expectations, the price dropped overnight by $5.20 to $243.63 as of 3am in the east. Adobe’s forward guidance on growth were not as impressive as the numbers put forward by Oracle.'
on Apple's iPhone Duo: What the analysts are saying - 'Well, FDA approval AND legal liability are true for all medical sensor uses of the Apple Watch or similar devices. But I strongly suspect when Apple’s close to getting blood sugar, we’ll hear about it from the FDA approval leaking. Blood sugar monitoring will pretty much pay for an Apple Watch, I’m spending about $75/month for Freestyle sensors (not covered by Medicare.)'
on Chart of the day: Tim Cook's value add - '“Buying back an equity that is growing >20% per annum is a much better investment than is balance sheet window dressing.” Upvoted.'
on Premarket: Apple is green - 'For a professional analyst to comment that the first half day’s price movement after an event is telling and proves (her own) theory is mind boggling. Comically uninformed and ludicrous.'
on Chart of the day: Tim Cook's value add - 'Thanks, Greg, but I think I erred. When I re-looked at the chart, the X-axis is kind of log also… per second. per minute, per hour, per day… and it’s the same data in each column, just restated. I’d probably avoid charts like this in the future. But I love this site.'
on Apple's iPhone Duo: What the analysts are saying - '@George Noninvasive glucose measurements are really hard. I’ve read some of the papers on this. Seems like everyone has settled on Raman spectroscopy to do the measurement. Raman is an infra-red spectroscopy. You hit the sample with a short, bright laser pulse then look for the after glow. Usual infrared spectroscopy looks at photons emitted from electrons changing energy levels in a molecule. Raman causes the long chain of carbon atoms in a molecule to resonate. Kind of like ringing a bell. It’s a great technique but it does not generate sharp peaks like you might expect. You get these broad spectra that are matched against a database for identification. I did a joint paper with a person supplying Raman data for me. It was very cool that he could identify the polymer layers in a potato chip bag even though they were fractions of a millimeter thick. Blood contains about 1% glucose. I find it amazing that they can even identify glucose at that low level, let alone try to quantify it using Raman.'
on Apple's iPhone Duo: What the analysts are saying - 'I’ve been thinking about the issue of left-handed users. It doesn’t seem to me that an orientation setting would be the answer since the Touch ID tab and the camera would be physically in the wrong locations. My guess is that there will be a separate SKU for a lefty iPhone Duo and Apple is just not ready to talk about it, probably working out the kinks in their production process and not yet in a position to manufacture one with slightly different innards and, more importantly, to commit to delivery dates. It’s not like Apple to have overlooked the obvious, what about lefties? If they are not talking about an orientation setting on day one it’s because that’s not the answer they’re looking for and are not yet ready to talk about availability of iPhone Duo-S, the Southpaw edition.'
on Premarket: Apple is green - 'I hope Laura Martin didn’t short the stock leading up to the event yesterday. But, at the very least, I’m sure she’s happy to see that her worry about the stock not moving at all after the announcement was unfounded.'
on Premarket: Apple is green - '” Now that’s what I like, a mini-melt up at end of day to +11.23, +3.56% to a near intraday high of $326.57.” As sweet as today was, it would have been sweeter if AAPL wasn’t just reclaiming ground lost since July 30. Still got $15 to go to match July 28 prints ($340). With October Earnings Report coming on October 27/28, Could $340 be AAPL’s near term slope? If it is, then on a positive October Earnings Report and GUIDANCE $365 could be in the cards for January.'
on Horace Dediu: How Apple finally won the enterprise buyer's heart - 'Well that kinda depends on how much of the stock you have! 🙂'
on Premarket: Apple is green - 'Now that’s what I like, a mini-melt up at end of day to +11.23, +3.56% to a near intraday high of $326.57. Volume was 56.6M shares. Wonder what Friday will bring? The more people talk about Apple, the more traffic Apple Stores get, and the more people try out the new Duo and iPhone 18 Pro models, the more interest gets drummed up. Don’t forget the new Watches and AirPods too!'
on Chart of the day: Tim Cook's value add - 'That quote is wrong. It’s $32,698,740 per hour — not per year.'
on Apple's iPhone Duo: What the analysts are saying - 'Lifelong insulin dependent diabetic here – also left handed and nearing 80. Ah yes, blood sugar monitoring. On your wrist and non invasive would be the holy grail. Of course we do have patches now (Libre, etc) that do continuously measure interstitial fluid blood sugar. Interstitial fluid in the fluid surrounding RBC’s. This is what current patches measure – not blood sugar directly but what leaks out of the capillaries. So the data from the patch is always behind the curve and is best a close approximation. And yes, Libre insures that it overstates the lows, so it can’t be sued successfully. Want the real data – you still have to prick your finger and measure the blood drop with your glucometer. Feel like a pin cushion most days, but I’m alive and very active!'
on Apple's iPhone Duo: What the analysts are saying - 'Neal Guttenberg said: “What a maroon.” **Neal, I was upvoting your comment anyway…and, since my wife is a big Bugs Bunny fan, your “maroon” comment really registered with me. Thanks for the chuckle. 🙂'
on Chart of the day: Tim Cook's value add - 'While it is fun to try and figure out the math of Apple’s Market cap increase under Cook’s term as CEO I doubt this is quite accurate. (Can’t seem to read the article easily on CNBC Pro) Apple’s stock buyback plays havoc with comparisons of market cap over time as share counts decrease over time making comparisons imprecise without a lot of adjustments. Market Cap is calculated by multiplying share price by stock price and having less shares means lower market cap at any given price. So Apple’s market cap could look lower than it would have been due to the buyback. Since Apple has been devoting most of its free cash flow to buybacks and dividend the impact on market cap is significant. Even if the stock price doesn’t reflect a dollar for dollar movement in the value of the company due to buybacks. Suffice to say Apple’s value as a company grew dramatically under Cook’s time as CEO and he deserves a lot of the credit. And just imagine how much cash Apple would have on hand if they hadn’t done the buy backs.'
on Apple's iPhone Duo: What the analysts are saying - 'I expect that the left-handedness is something Apple will fix in an update under accessibility. Can’t have a perfect 1.0 version 😉 Talking about services. While pricing out a Duo I noticed this: on 9/14 Apple will make available a new AppleCare service. AppleCare One Family. For $50 it will cover ALL the eligible devices for an entire Family Sharing group of up to 6 peoiple. An Individual plan costs $20 a month for 3 devices. If I am counting correctly, between my family and my son’s we have 14 devices. I’m going to chat with him about combining our AppleCare. It covers current devies and new ones. And no more than 6 claims a year.'
